MMA Embolization for Migraine: Patient-Reported Outcomes from a Single Site

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

EMBRACE-OBS is a single-site registry that uses data already collected in routine care to describe how headache frequency, headache severity, and migraine-related quality of life change after MMA embolization. It does not change how patients are treated or followed. The study also documents medication use and any adverse events to understand the real-world safety and impact of the procedure. Follow-up relies on standard clinical visits and patient-reported measures such as headache diaries and validated questionnaires.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 18 to 64 years
* Diagnosis of migraine
* Have undergone or plan to undergo middle meningeal artery (MMA) embolization as part of routine clinical care, independent of study participation
* Able and willing to provide informed consent
* Able to read and understand English sufficiently to complete informed consent and patient-reported outcome assessments

Exclusion Criteria:

* Age under 18 years
* Pregnancy at the time of enrollment
* Inability to provide informed consent
* Inability to read and understand English sufficiently to complete informed consent and patient-reported outcome assessments
* Insufficient clinical or patient-reported outcome data for the planned analyses

Where it's running

• Cortex Neurovascular / TRA Union
  Tacoma, Washington, United States Recruiting

Study contacts

• Study coordinator: Dennis Wang, Principal Investigator, MD
• Email: dwang@cortexmgmt.com
• Phone: 253-284-0841

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Analyzing CGRP Levels in Migraine Patients by Age and Sex

  This study looks at the levels of a substance linked to migraines in people with migraines and healthy individuals to see how age and sex might affect treatment responses.

  Recruiting Hospital Universitari Vall d'Hebron Research Institute · Barcelona, Barcelona · NCT06674772

• HEADS Registry: Headache, Ear, Auditory, Dizziness, and Sinus</n> Registry

  This registry tests whether collecting online symptom reports from adults in the U.S. with sinus, vestibular, ear, or headache symptoms can help improve diagnosis and treatment.

  Recruiting Association of Migraine Disorders · North Kingstown, Rhode Island · NCT07754266

• Bilateral middle meningeal artery embolization for refractory chronic migraine

  This study will try blocking both middle meningeal arteries with Onyx in adults who have refractory bilateral chronic migraine to see if it is safe and lowers headaches.

  Recruiting Johns Hopkins University · Baltimore, Maryland · NCT07223008

• Real-world use of anti-CGRP medicines for preventing migraine

  This project will follow people with episodic or chronic migraine who start anti-CGRP medicines to see if the treatments reduce migraine frequency and side effects over two years.

  Recruiting at 25 sites Hospital Universitari Vall d'Hebron Research Institute · Miami, Florida and 25 other locations · NCT07159750

• New methods to test preventive migraine treatment

  This trial will test how the active medicine, placebo injections, and the information given about them affect symptoms in adults with chronic migraine.

  Recruiting at 2 sites University of Aarhus · Aarhus C, Denmark and 1 other locations · NCT07071506

• Nordic comparison of CGRP antibody plus onabotulinumtoxinA (Botox) versus CGRP antibody alone for chronic migraine

  This trial will test whether adding onabotulinumtoxinA (Botox) to a CGRP monoclonal antibody reduces monthly headache days in adults with chronic migraine.

  Recruiting Phase 3 Oslo University Hospital · Grålum and 5 other locations · NCT07040813

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.